Q1 FY27 transcript: revenue up 22%, EBITDA up 27%, service guide INR90-100cr

Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansOrder Pipeline DisclosedInvestor Communications View source PDF Explain this filing

QMSMEDI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Q1 FY27 earnings call transcript filed. Consolidated revenue INR56.9cr, up 22% YoY. EBITDA INR8.3cr, up 27% YoY, margin expanded to 14.6% from 14.1%. PAT INR4cr, up 25% YoY. PSP revenue INR17.6cr, B2B camps 11,497. Migrated to NSE main board on June 18, 2026. Plans to acquire remaining 24% stake in Saarathi Healthcare by Q2 FY27 end. FY27 guidance maintained: revenue around INR220cr, EBITDA margin 18%, service revenue INR90-100cr, PSP revenue INR100-105cr.

Likely market impact

Strong quarter with revenue, EBITDA and PAT all growing faster than last year. Margin expansion and main board migration support a positive view.